Editor's Note The Joint Commission has launched a new strategy to revise its accreditation and certification programs to better reflect the distinct needs of pediatric care. According to a July 29 announcement, the effort responds to requests from the children’s health community and aims to revise or remove standards that…
Editor's Note Major for-profit health systems are accelerating investments in ambulatory surgery centers (ASCs) as they brace for long-term revenue reductions under the federal “One Big Beautiful Bill” tax law. Systems including HCA Healthcare, Tenet Healthcare, Community Health Systems (CHS), and Universal Health Services (UHS) outlined aggressive ASC growth strategies…
Editor's Note Regular check-ins and visible leadership can help ambulatory surgery centers (ASCs) head off legal trouble before it starts. That is the central message from employment attorney Salvatore Puccio on a recent episode of the Advancing Surgical Care Podcast, Ambulatory Surgery Center News July 23 reports. Puccio, a partner…
Editor's Note Hospital-employed physicians are least likely and private equity (PE)-affiliated physicians most likely to provide care in lower-cost ambulatory surgery centers (ASCs) or offices, according to a study published July 24 in the Journal of Market Access & Health Policy These care site differences translate to substantial variation in…
Editor's Note US News & World Report has named 504 hospitals across 49 states and 95 metro areas to its 2025–2026 list of Best Regional Hospitals, recognizing facilities with superior performance in patient outcomes, nursing care, and procedural quality. The announcement, made July 29, marks the 36th edition of the…
Editor's Note Postoperative delirium significantly worsens outcomes for older adults undergoing major noncardiac surgery, according to research published July 8 in JAMA Network Open. Specifically, findings showed patients who developed postoperative delirium had 3.5 times the odds of death or major complications, 2.8 times the odds of 30-day mortality, and…
Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…
Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Ethicon Endo-Surgery, LLC’s Endopath Echelon Vascular White Reload for Advanced Placement Tip a Class I, the most severe category indicating risk of serious injury or death. As detailed in the agency’s July 25 announcement, the recall…
Editor's Note The US Food and Drug Administration (FDA) has designated a Class I recall—the most severe category indicating risk of serious injury or death—for several models of arterial cannulae manufactured by Edwards Lifesciences. Affected products include OptiSite Arterial Perfusion Cannula models OPTI16 and OPTI18, as well as Peripheral Femoral…
Editor's Note The US Food and Drug Administration (FDA) has designated Baxter’s recall of the Q-Link 13 mobile lift component a Class I, the most severe category indicating risk of serious injury or death. As detailed in the agency’s July 23 announcement, the optional component connects to sling bars on…